Results 161 to 170 of about 5,408 (223)

Shift in Patient Demographics of Open Thoracoabdominal Aortic Aneurysm Repair Patients in the Endovascular Era. [PDF]

open access: yesJ Clin Med
Frankort J   +7 more
europepmc   +1 more source

Creating a Cardio-Obstetrics Elective as a Fellow in Training. [PDF]

open access: yesJACC Case Rep
Varma B   +5 more
europepmc   +1 more source

Activating PRKG1 Variant Enhances Smooth Muscle Cell Deformability to Cause Aortopathy. [PDF]

open access: yesJACC Basic Transl Sci
Jost ME   +38 more
europepmc   +1 more source

Aortopathy in pregnancy

Heart, 2022
Aortic dissection is one of the most common causes of death in pregnancy. Most cases are caused by hereditary thoracic aortopathy (HTA), and women are often unaware they are at risk. Awareness, early recognition and involvement of senior clinicians from the expert cardio-obstetric team are essential to facilitate early diagnosis and carefully planned ...
Stephanie Louise Curtis, Lorna Swan
openaire   +2 more sources

Imaging of Genetic Thoracic Aortopathy

RadioGraphics, 2022
Aortopathy is a term most commonly used to describe a group of genetic diseases that predispose patients to an elevated risk of aortic events including aneurysm and acute aortic syndrome. Types of genetic aortopathy are classified as either heritable or congenital, with heritable thoracic aortic disease (HTAD) further subclassified into syndromic HTAD ...
Kacie L. Steinbrecher   +7 more
openaire   +2 more sources

The science of BAV aortopathy

Progress in Cardiovascular Diseases, 2020
The aortopathy associated with bicuspid aortic valve (BAV) is an epidemiologically relevant source of chronic and acute aortic disease (aneurysm and dissection). However, its pathogenesis is still the object of scientific uncertainties and debates. Indeed, the mechanisms determining the diseases of the ascending aorta in BAV patients are most likely ...
Lo Presti, Federica   +4 more
openaire   +3 more sources

Genetic Biomarkers in Aortopathy

Biomarkers in Medicine, 2013
The field of aortopathy, in common with other genomic disorders, is undergoing a revolution. This is largely driven by the implementation of newer forms of genetic sequencing (massively parallel or next-generation sequencing). Advantages conferred by this technology include reduced costs, reduced sequencing time and the ability to simultaneously test ...
Gillian, Rea, Fiona J, Stewart
openaire   +2 more sources

Home - About - Disclaimer - Privacy